Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1324 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
This article has been cited by
1Fludrocortisone-a treatment for tubulopathy post-paediatric renal transplantation: A national paediatric nephrology unit experience
S. R. Ali,I. Shaheen,D. Young,I. Ramage,H. Maxwell,D. A. Hughes,D. Athavale,M. G. Shaikh
Pediatric Transplantation.2018;22(2)e13134
[DOI]
2Tacrolimus
S. R. Ali,I. Shaheen,D. Young,I. Ramage,H. Maxwell,D. A. Hughes,D. Athavale,M. G. Shaikh
Reactions Weekly.2014;1494(1)42
[DOI]
3Tacrolimus-Induced Type IV Renal Tubular Acidosis following Liver Transplantation
Christopher Schmoyer,Suraj Mishra,Frank Fulco
Case Reports in Hepatology.2017;2017(1)1
[DOI]
4Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine,Bradley S Dixon
Clinical Investigation.2015;5(10)805
[DOI]
5How Dangerous Is Hyperkalemia?
John R. Montford,Stuart Linas
Journal of the American Society of Nephrology.2017;28(11)3155
[DOI]
6Calcineurin inhibitor-associated electrolyte disturbances after pediatric renal transplantation: Could fludrocortisone therapy have a role?
Juuso Tainio
Pediatric Transplantation.2018;22(2)e13097
[DOI]
7The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
Samira S. Farouk,Joshua L. Rein
Advances in Chronic Kidney Disease.2020;27(1)56
[DOI]
  My Preferences